Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07581340 · ClinicalTrials.gov registry record · NA
Using AI to Improve Sepsis Quality of Care in the Emergency Department
A NA study, sponsored by University of California, San Diego.
- Completed
- Registry status
- NA
- Development phase
- 66
- Enrollment target
NCT07581340 is a NA study that has completed, run by University of California, San Diego. The registered enrollment target is 66 participants.
The verdict
NCT07581340, a NA study, has completed, sponsored by University of California, San Diego.
- COMPLETED
- Registry status
- NA
- Development phase
- 66 participants
- Enrollment target
Study Summary
Sepsis is a life-threatening condition caused by the body's response to infection and is a leading cause of death worldwide. Hospitals use a complex quality measure called SEP-1 to track whether patients with severe sepsis or septic shock receive recommended care, such as timely antibiotics, fluids, and laboratory testing. However, evaluating SEP-1 is difficult. It requires manual review of medical records, is time-consuming and expensive, and typically provides feedback to clinicians months after care is delivered. This delay limits the ability to improve care in real time. This study tested whether artificial intelligence (AI), specifically a type of system called a large language model (LLM), could improve the quality of sepsis care by providing faster and more detailed feedback to physicians. The study was conducted at two emergency departments within a large academic health system. Sixty-six attending physicians were randomly assigned to one of two groups. In the intervention group, the AI system reviewed each patient's medical record at the time of hospital discharge and determined whether SEP-1 care standards were met. Physicians then received near real-time, individualized feedback about their performance, including specific areas for improvement. In the control group, physicians received standard feedback based on a small sample of cases reviewed months later using traditional methods.
Interventions
- BEHAVIORAL Near-real time automated feedback on SEP-1 performance
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 66 participants |
| Start Date | 2024-12-01 |
| Est. Completion | 2025-12-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07581340
The ClinicalTrials.gov registry entry for NCT07581340 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 66 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Diego, which has 775 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Near-real time automated feedback on SEP-1 performance is the first listed.
NCT07581340 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07581340 about?
NCT07581340 is a clinical study titled "Using AI to Improve Sepsis Quality of Care in the Emergency Department". Sepsis is a life-threatening condition caused by the body's response to infection and is a leading cause of death worldwide. Hospitals use a complex quality measure called SEP-1 to track whether patients with severe sepsis or septic shock receive recommended care, such as timely antibiotics, fluids,...
What is the current status of trial NCT07581340?
This trial is currently completed. It is a NA study. The enrollment target is 66 participants. The study started on 2024-12-01. Estimated completion is 2025-12-12.
What interventions are being tested in trial NCT07581340?
The interventions under investigation include: Near-real time automated feedback on SEP-1 performance (BEHAVIORAL).
Who is sponsoring clinical trial NCT07581340?
This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.